Bridgepoint reports record first-half results.


Bridgepoint reported record first-half results as strong fundraising and investment performance drove a 78% increase in underlying EBITDA to £227.3m, while fee-paying assets under management rose 32.7% to $58.4bn.

  • Bridgepoint Group (Reg S)
  • 17 July 2026 09:04:37
Bridgepoint Group

Source: Sharecast

Underlying management fee income increased 22.8% to £254.4m, performance-related earnings more than doubled to £120.7m and assets under management grew 12.4% to $97.3bn, with the private markets group saying it had now raised €26bn towards its recently increased €28bn fundraising target by the end of 2026.

The company returned a record €16.6bn to fund investors during the first half, including €11bn from the sale of Calpine, while deploying €3.6bn of capital.

Bridgepoint also highlighted its planned acquisition of Kayne Anderson Real Estate, announced in June, which it said would strengthen its position in the growing real estate market, and declared an interim dividend of 4.8p per share as it reiterated confidence in delivering its upgraded guidance.

At 0936 BST, shares in Birdgepoint Group were up 5.22% at 330.4p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: -111.00 ( -0.47 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.